Mark P. Breazzano

1.1k total citations
75 papers, 522 citations indexed

About

Mark P. Breazzano is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Mark P. Breazzano has authored 75 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Ophthalmology, 15 papers in Radiology, Nuclear Medicine and Imaging and 13 papers in Molecular Biology. Recurrent topics in Mark P. Breazzano's work include Retinal Diseases and Treatments (28 papers), Retinal and Optic Conditions (15 papers) and Ocular Infections and Treatments (13 papers). Mark P. Breazzano is often cited by papers focused on Retinal Diseases and Treatments (28 papers), Retinal and Optic Conditions (15 papers) and Ocular Infections and Treatments (13 papers). Mark P. Breazzano collaborates with scholars based in United States, Italy and Spain. Mark P. Breazzano's co-authors include Lawrence A. Yannuzzi, Sean P. Donahue, John Bond, Serena Fragiotta, Richard F. Spaide, K. Bailey Freund, Royce W. S. Chen, Timothy W. Olsen, Karen C. Bloch and Flora Lum and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Ophthalmology.

In The Last Decade

Mark P. Breazzano

60 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark P. Breazzano United States 12 349 146 111 72 71 75 522
Cong Ye China 13 313 0.9× 257 1.8× 273 2.5× 84 1.2× 51 0.7× 21 765
Royce W. S. Chen United States 12 265 0.8× 133 0.9× 21 0.2× 107 1.5× 27 0.4× 43 460
Jason Horowitz United States 9 176 0.5× 169 1.2× 28 0.3× 32 0.4× 38 0.5× 36 345
Jemshed A. Khan United States 14 331 0.9× 95 0.7× 35 0.3× 74 1.0× 134 1.9× 40 634
Mrittika Sen India 8 294 0.8× 70 0.5× 250 2.3× 38 0.5× 54 0.8× 25 562
Kathleen Stoessel United States 12 239 0.7× 90 0.6× 53 0.5× 34 0.5× 51 0.7× 16 572
Allison R. Loh United States 13 380 1.1× 137 0.9× 15 0.1× 56 0.8× 76 1.1× 24 561
Ghazala O’Keefe United States 12 335 1.0× 100 0.7× 58 0.5× 53 0.7× 42 0.6× 27 510
Xingguang Qu China 5 599 1.7× 133 0.9× 261 2.4× 46 0.6× 40 0.6× 16 906
Charles Makin United States 10 49 0.1× 46 0.3× 21 0.2× 49 0.7× 45 0.6× 26 397

Countries citing papers authored by Mark P. Breazzano

Since Specialization
Citations

This map shows the geographic impact of Mark P. Breazzano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark P. Breazzano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark P. Breazzano more than expected).

Fields of papers citing papers by Mark P. Breazzano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark P. Breazzano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark P. Breazzano. The network helps show where Mark P. Breazzano may publish in the future.

Co-authorship network of co-authors of Mark P. Breazzano

This figure shows the co-authorship network connecting the top 25 collaborators of Mark P. Breazzano. A scholar is included among the top collaborators of Mark P. Breazzano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark P. Breazzano. Mark P. Breazzano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, James, et al.. (2025). Utility of Screening Examination for Cytomegalovirus Retinitis Among Patients With Cytomegalovirus Viremia. American Journal of Ophthalmology. 277. 230–241. 1 indexed citations
2.
Thompson, Krista A., Bita Momenaei, Thomas F. Jenkins, et al.. (2025). Visual Outcomes in Cases of Endogenous Endophthalmitis. Ophthalmology Retina. 10(1). 61–70.
4.
Christensen, Cory A., et al.. (2025). Novel Bilateral Geographic Atrophy Phenotype Associated With CRX Mutation. Journal of VitreoRetinal Diseases. 10(1). 157–161.
5.
Zhang, Sean X., et al.. (2024). Povidone-iodine in vitro antiseptic efficacy as a function of exposure duration, concentration, preparation, and length of storage. Graefe s Archive for Clinical and Experimental Ophthalmology. 262(12). 4005–4012. 1 indexed citations
6.
Carvalho, José Ronaldo Lima de, et al.. (2023). Phenotypic Variability of Retinal Disease Among a Cohort of Patients With Variants in the CLN Genes. Investigative Ophthalmology & Visual Science. 64(3). 23–23. 8 indexed citations
7.
Lin, Andrew, Etienne M. Schönbach, Delu Song, et al.. (2023). The Sensitivity of Ultra-Widefield Fundus Photography Versus Scleral Depressed Examination for Detection of Retinal Horseshoe Tears. American Journal of Ophthalmology. 255. 155–160. 6 indexed citations
9.
Zhang, Sean X., et al.. (2022). Characterizing the microbiota of instrumentation in ophthalmology clinics during and beyond the COVID-19 pandemic. Graefe s Archive for Clinical and Experimental Ophthalmology. 260(8). 2585–2590. 1 indexed citations
10.
Breazzano, Mark P., et al.. (2022). Novel MFSD8 mutation causing non-syndromic asymmetric adult-onset macular dystrophy. Ophthalmic Genetics. 44(2). 186–190. 7 indexed citations
11.
Breazzano, Mark P., et al.. (2021). RETINAL RACEMOSE HEMANGIOMA (RETINAL ARTERIOVENOUS COMMUNICATION) DIAGNOSED AND MANAGED WITH MULTIMODAL IMAGING. Retinal Cases & Brief Reports. 17(3). 279–284.
12.
Breazzano, Mark P.. (2020). Choroidal origin of endogenous Candida endophthalmitis. BMC Ophthalmology. 20(1). 283–283. 5 indexed citations
13.
Breazzano, Mark P., Aliaa H. Abdelhakim, Lora R. Dagi Glass, et al.. (2020). New York City COVID-19 resident physician exposure during exponential phase of pandemic. Journal of Clinical Investigation. 130(9). 4726–4733. 56 indexed citations
14.
Breazzano, Mark P., et al.. (2019). Endogenous Serratia marcescens panophthalmitis: A case series. American Journal of Ophthalmology Case Reports. 16. 100531–100531. 6 indexed citations
15.
Fragiotta, Serena, et al.. (2019). Linear and planar reflection artifacts on swept-source and spectral-domain optical coherence tomography due to hyperreflective crystalline deposits. Graefe s Archive for Clinical and Experimental Ophthalmology. 258(3). 491–501. 12 indexed citations
16.
Breazzano, Mark P., et al.. (2018). CLEARED (Chemicals and Litmus testing with Effective Alkaline Range for Eye Damage): A Prospective, Interventional Study. Academic Emergency Medicine. 26(7). 796–802. 1 indexed citations
17.
Breazzano, Mark P., et al.. (2017). Multiple and Bilateral Cilioretinal Arteries with Shwachman-Diamond Syndrome. Ophthalmology. 124(9). 1352–1352. 1 indexed citations
18.
Breazzano, Mark P., Janice C. Law, & Patrick Lavin. (2017). Simultaneous Traumatic Central Retinal Artery Occlusion and Optic Neuropathy. Ophthalmology. 124(11). 1661–1661.
19.
Breazzano, Mark P. & Anthony B. Daniels. (2017). Initial staging imaging for uveal melanoma: what’s necessary and what’s extraneous?. Investigative Ophthalmology & Visual Science. 58(8). 4412–4412. 1 indexed citations
20.
Breazzano, Mark P., et al.. (2017). HHV-1, -2, -3: Precise medical management of herpetic nodular anterior scleritis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026